Evidence Explorer · MS-N057

Dignity therapy for distress near the end of life

Family: Palliative psychological and legacy-focused care
Clinical question: Does dignity therapy reduce distress or improve quality of life for people with terminal illness receiving palliative care?
Evidence label: Primary distress outcomes were null; subjective helpfulness may still matter.

Evidence at a glance

• Benefit: The main randomized trial did not improve prespecified distress outcomes, although participants more often described the intervention as helpful and beneficial to family.
• Certainty: A multisite randomized trial plus later reviews; pooled quality-of-life effects remain uncertain or null.
• Risk: Recounting life and relationships can be emotionally taxing; trained facilitation and clinical backup matter.
• Cancer control: Not an anticancer intervention.

What was studied

A three-country trial randomized 326 terminally ill patients receiving palliative care to dignity therapy (108), client-centered care (107), or standard palliative care (111). Dignity therapy used a brief, recorded therapist interview to create an edited legacy document for the patient.

What the evidence shows

There were no statistically significant differences on the primary pre-to-post distress outcomes. On post-study ratings, dignity-therapy participants were more likely to describe the intervention as helpful, to report improved perceived quality of life or dignity, and to see benefit for family. Those ratings were subjective and unblinded. A 2023 review found ten randomized trials; pooled quality-of-life data from four trials did not show a significant effect.

What this does not show: The therapy does not treat the cancer, prolong life, or replace expert palliative symptom management. A meaningful legacy experience should not be relabeled as proven reduction in clinical distress.

Limits and uncertainty

• The primary trial’s prespecified distress outcomes were null.
• Participants knew which intervention they received, making subjective helpfulness ratings vulnerable to expectancy and gratitude effects.
• End-of-life attrition and missing data are difficult to avoid and can bias estimates.
• Intervention fidelity depends on trained therapists, editing, and family context.

Safety and practical context

Some people welcome a life-review conversation; others may experience grief, guilt, conflict, or exhaustion. Participation should be optional and paced. Uncontrolled symptoms, delirium, severe depression, or suicidal thoughts need direct clinical assessment; dignity therapy is not crisis treatment.

Questions for the care team

• Does the patient want a recorded life-review and legacy document?
• Is a trained therapist available, with time to edit and return the document?
• Could family conflict, trauma, cognitive impairment, or exhaustion make this burdensome?
• Are palliative symptoms and urgent psychological needs being treated directly?

Sources

• Primary randomized trial (Lancet Oncol; PMID 21741309)
• Primary trial full text (PMCID PMC3185066)
• 2023 systematic review and meta-analysis (PMCID PMC9941428)

Identifiers: PMID 21741309; PMCID PMC3185066; systematic review PMCID PMC9941428
Last literature search: October 17, 2026
Record appraised: October 17, 2026

Educational information, not personal medical advice. Decisions about symptoms, supplements, movement, or psychological care during cancer treatment should be made with the oncology team.